XML 80 R70.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business Combination (Details) - USD ($)
$ in Thousands
 3 Months Ended 5 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Business Combination (Details) [Line Items]        
Business acquisition description     The aggregate consideration for the Lab Society Acquisition consisted of: (a) $4.0 million in cash, subject to certain adjustments for working capital, cash, and indebtedness of Lab Society at closing; (b) 425,611 shares of Common Stock (the “Buyer Shares”); and (c) the Earn-out Consideration (as defined below), to the extent earned.   
Transaction and related costs $ 38   $ 66  
Interest purchase     30,000  
Subject to adjustment, equal to the quotient     20,000  
Purchase agreement amount     $ 65,000  
Fair value of the contingent earn-out consideration       $ 5,600
Buyer shares issuable to certain members (in Shares)     88,878  
Pure purchase agreement, description     The Pure Purchase Agreement includes customary post-closing adjustments, representations and warranties and covenants of the parties. The Members may become entitled to additional consideration with a value of up to $3.0 million based on the eligible net revenues achieved by the PurePressure business during the fiscal years ending December 31, 2022 and December 31, 2023, of which 40% will be payable in cash and the remaining 60% will be payable by issuing shares of Common Stock (collectively, the “Earn-out Consideration”).  
Holdback Lab Buyer Shares [Member]        
Business Combination (Details) [Line Items]        
Shares issuable (in Shares) 127,682 127,682 127,682  
Acquisition of Lab Society [Member]        
Business Combination (Details) [Line Items]        
Business acquisition description     The Owners may become entitled to additional consideration with a value of up to $3.5 million based on the eligible net revenues achieved by the Lab Society business during the fiscal years ending December 31, 2022 and December 31, 2023, of which 50% will be payable in cash and the remaining 50% will be payable by issuing shares of Common Stock.  
Revenue   $ 3,100    
Cascade Sciences, LLC [Member]        
Business Combination (Details) [Line Items]        
Equity interest percentage 100.00% 100.00% 100.00%  
PurePressure [Member]        
Business Combination (Details) [Line Items]        
Transaction and related costs $ 1   $ 563  
Intangible assets acquired     $ 4,000  
Common stock (in Shares) 329,179 329,179 329,179